vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $120.9M, roughly 1.4× Sprout Social, Inc.). On growth, Sprout Social, Inc. posted the faster year-over-year revenue change (12.9% vs -22.7%). Sprout Social, Inc. produced more free cash flow last quarter ($9.9M vs $-36.6M). Over the past eight quarters, Sprout Social, Inc.'s revenue compounded faster (11.8% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

PTCT vs SPT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.4× larger
PTCT
$164.7M
$120.9M
SPT
Growing faster (revenue YoY)
SPT
SPT
+35.6% gap
SPT
12.9%
-22.7%
PTCT
More free cash flow
SPT
SPT
$46.5M more FCF
SPT
$9.9M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
SPT
SPT
Annualised
SPT
11.8%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
SPT
SPT
Revenue
$164.7M
$120.9M
Net Profit
$-135.0M
Gross Margin
77.6%
Operating Margin
-43.3%
-9.0%
Net Margin
-82.0%
Revenue YoY
-22.7%
12.9%
Net Profit YoY
-104.8%
EPS (diluted)
$-1.63
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SPT
SPT
Q4 25
$164.7M
$120.9M
Q3 25
$211.0M
$115.6M
Q2 25
$178.9M
$111.8M
Q1 25
$1.2B
$109.3M
Q4 24
$213.2M
$107.1M
Q3 24
$196.8M
$102.6M
Q2 24
$186.7M
$99.4M
Q1 24
$210.1M
$96.8M
Net Profit
PTCT
PTCT
SPT
SPT
Q4 25
$-135.0M
Q3 25
$15.9M
$-9.4M
Q2 25
$-64.8M
$-12.0M
Q1 25
$866.6M
$-11.2M
Q4 24
$-65.9M
Q3 24
$-106.7M
$-17.1M
Q2 24
$-99.2M
$-16.9M
Q1 24
$-91.6M
$-13.6M
Gross Margin
PTCT
PTCT
SPT
SPT
Q4 25
77.6%
Q3 25
77.7%
Q2 25
77.7%
Q1 25
77.3%
Q4 24
78.1%
Q3 24
77.4%
Q2 24
77.5%
Q1 24
76.8%
Operating Margin
PTCT
PTCT
SPT
SPT
Q4 25
-43.3%
-9.0%
Q3 25
1.4%
-7.9%
Q2 25
-19.5%
-11.0%
Q1 25
82.5%
-10.2%
Q4 24
-76.2%
-12.8%
Q3 24
-27.7%
-16.4%
Q2 24
-21.5%
-16.6%
Q1 24
-21.6%
-13.7%
Net Margin
PTCT
PTCT
SPT
SPT
Q4 25
-82.0%
Q3 25
7.5%
-8.1%
Q2 25
-36.3%
-10.7%
Q1 25
73.7%
-10.3%
Q4 24
-30.9%
Q3 24
-54.2%
-16.6%
Q2 24
-53.1%
-17.0%
Q1 24
-43.6%
-14.0%
EPS (diluted)
PTCT
PTCT
SPT
SPT
Q4 25
$-1.63
$-0.18
Q3 25
$0.20
$-0.16
Q2 25
$-0.83
$-0.21
Q1 25
$10.04
$-0.19
Q4 24
$-0.85
$-0.25
Q3 24
$-1.39
$-0.30
Q2 24
$-1.29
$-0.30
Q1 24
$-1.20
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$1.9B
$95.3M
Total DebtLower is stronger
$40.0M
Stockholders' EquityBook value
$-205.3M
$203.4M
Total Assets
$2.9B
$523.1M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SPT
SPT
Q4 25
$1.9B
$95.3M
Q3 25
$1.7B
$90.6M
Q2 25
$2.0B
$101.5M
Q1 25
$2.0B
$100.9M
Q4 24
$1.1B
$86.4M
Q3 24
$1.0B
$82.9M
Q2 24
$1.1B
$80.9M
Q1 24
$884.8M
$69.2M
Total Debt
PTCT
PTCT
SPT
SPT
Q4 25
$40.0M
Q3 25
Q2 25
Q1 25
Q4 24
$25.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PTCT
PTCT
SPT
SPT
Q4 25
$-205.3M
$203.4M
Q3 25
$-155.8M
$194.1M
Q2 25
$-206.5M
$184.6M
Q1 25
$-185.8M
$175.3M
Q4 24
$-1.1B
$166.6M
Q3 24
$-1.1B
$158.1M
Q2 24
$-980.2M
$152.1M
Q1 24
$-893.9M
$147.3M
Total Assets
PTCT
PTCT
SPT
SPT
Q4 25
$2.9B
$523.1M
Q3 25
$2.6B
$481.4M
Q2 25
$2.6B
$422.9M
Q1 25
$2.7B
$424.7M
Q4 24
$1.7B
$428.3M
Q3 24
$1.8B
$388.8M
Q2 24
$1.9B
$393.6M
Q1 24
$1.8B
$389.9M
Debt / Equity
PTCT
PTCT
SPT
SPT
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SPT
SPT
Operating Cash FlowLast quarter
$-34.3M
$10.9M
Free Cash FlowOCF − Capex
$-36.6M
$9.9M
FCF MarginFCF / Revenue
-22.3%
8.2%
Capex IntensityCapex / Revenue
1.4%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SPT
SPT
Q4 25
$-34.3M
$10.9M
Q3 25
$-66.3M
$9.3M
Q2 25
$-58.3M
$5.1M
Q1 25
$870.1M
$18.1M
Q4 24
$-30.0M
$4.1M
Q3 24
$-77.0M
$9.0M
Q2 24
$-71.5M
$2.1M
Q1 24
$70.8M
$11.2M
Free Cash Flow
PTCT
PTCT
SPT
SPT
Q4 25
$-36.6M
$9.9M
Q3 25
$-69.7M
$8.5M
Q2 25
$-59.6M
$4.2M
Q1 25
$868.4M
$16.7M
Q4 24
$-33.8M
$3.3M
Q3 24
$-77.5M
$8.5M
Q2 24
$-78.8M
$1.6M
Q1 24
$61.2M
$10.1M
FCF Margin
PTCT
PTCT
SPT
SPT
Q4 25
-22.3%
8.2%
Q3 25
-33.1%
7.4%
Q2 25
-33.3%
3.7%
Q1 25
73.8%
15.3%
Q4 24
-15.8%
3.0%
Q3 24
-39.4%
8.3%
Q2 24
-42.2%
1.6%
Q1 24
29.1%
10.4%
Capex Intensity
PTCT
PTCT
SPT
SPT
Q4 25
1.4%
0.9%
Q3 25
1.6%
0.7%
Q2 25
0.7%
0.8%
Q1 25
0.1%
1.2%
Q4 24
1.8%
0.8%
Q3 24
0.3%
0.5%
Q2 24
4.0%
0.5%
Q1 24
4.6%
1.1%
Cash Conversion
PTCT
PTCT
SPT
SPT
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
1.00×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons